41 – 50 of 140
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Quantification of total apolipoprotein e and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases
Minta, K. ; Brinkmalm, G. ; Janelidze, S. LU ; Sjödin, S. ; Portelius, E. ; Stomrud, E. LU
; Zetterberg, H.
LU
; Blennow, K.
LU
; Hansson, O.
LU
and Andreasson, U.
(2020)
In Alzheimer's Research and Therapy
12(1).
- Contribution to journal › Article
-
Mark
A LC–MS/MS method for the quantification of caffeine, betamethasone, clonidine and furosemide in cerebrospinal fluid of preterm infants
Romantsik, Olga LU ; Barco, Sebastiano ; Bruschettini, Matteo LU
; Tripodi, Gino
; Ley, David
LU
and Cangemi, Giuliana
(2020)
In Journal of Pharmaceutical and Biomedical Analysis
179.
- Contribution to journal › Article
- 2019
-
Mark
Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease : Cross-validation study of practical algorithms
Palmqvist, Sebastian LU
; Insel, Philip S.
LU
; Zetterberg, Henrik
LU
; Blennow, Kaj
LU
; Brix, Britta
; Stomrud, Erik
LU
; Mattsson, Niklas
LU
and Hansson, Oskar
LU
(2019)
In Alzheimer's and Dementia
15(2).
p.194-204
- Contribution to journal › Article
-
Mark
Cisterna Magna Injection in Rats to Study Glymphatic Function
Ramos, Marta LU
; Burdon Bechet, Nicholas
LU
; Battistella, Roberta
LU
; Pavan, Chiara
LU
; Xavier, Anna L.R.
; Nedergaard, Maiken
and Lundgaard, Iben
LU
(2019)
In Methods in molecular biology (Clifton, N.J.)
1938.
p.97-104
- Contribution to journal › Article
-
Mark
PDGF-B Is Required for Development of the Glymphatic System
- Contribution to journal › Article
-
Mark
Novel tau fragments in cerebrospinal fluid : relation to tangle pathology and cognitive decline in Alzheimer’s disease
Cicognola, Claudia ; Brinkmalm, Gunnar ; Wahlgren, Jessica ; Portelius, Erik ; Gobom, Johan ; Cullen, Nicholas C. ; Hansson, Oskar LU
; Parnetti, Lucilla
; Constantinescu, Radu
and Wildsmith, Kristin
, et al.
(2019)
In Acta Neuropathologica
137(2).
p.279-296
- Contribution to journal › Article
-
Mark
Towards a unified protocol for handling of CSF before β-amyloid measurements
Janelidze, Shorena LU ; Stomrud, Erik LU
; Brix, Britta
and Hansson, Oskar
LU
(2019)
In Alzheimer's Research and Therapy
11(1).
- Contribution to journal › Article
-
Mark
α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson’s disease patients
Paslawski, Wojciech ; Zareba-Paslawska, Justyna ; Zhang, Xiaoqun ; Hölzl, Katharina ; Wadensten, Henrik ; Shariatgorji, Mohammadreza ; Janelidze, Shorena LU ; Hansson, Oskar LU
; Forsgren, Lars
and Andrén, Per E.
, et al.
(2019)
In Proceedings of the National Academy of Sciences of the United States of America
116(30).
p.15226-15235
- Contribution to journal › Article
-
Mark
Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS
Shaw, Leslie M. ; Hansson, Oskar LU
; Manuilova, Ekaterina
; Masters, Colin L.
; Doecke, James D.
; Li, Qiao Xin
; Rutz, Sandra
; Widmann, Monika
; Leinenbach, Andreas
and Blennow, Kaj
LU
(2019)
In Clinical Biochemistry
72.
p.7-14
- Contribution to journal › Article
-
Mark
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
Hansson, Oskar LU
; Lehmann, Sylvain
; Otto, Markus
; Zetterberg, Henrik
LU
and Lewczuk, Piotr
(2019)
In Alzheimer's Research and Therapy
11(1).
p.1-15
- Contribution to journal › Scientific review